Physician profile
Daniel Mcmahon
NPI 1700025251
$30,082.68
in general payments reported to CMS, 2019-2025
15 companies · $13K in 2025
The $13K reported for 2025 was more than what 96% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $3,235 · 2021: $727 · 2022: $4,556 · 2023: $448 · 2024: $8,145 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Travel and Lodging: $2,342 · Food and Beverage: $1,599 · Education: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,875.00 |
| Travel and Lodging | $2,341.56 |
| Food and Beverage | $1,598.55 |
| Education | $750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $12,385.07 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Virtual Incision Corporation | $7,702.00 | 2024 | Mira |
| Intuitive Surgical, INC. | $4,528.62 | 2020-2025 | Da Vinci Surgical System |
| Ambu INC. | $4,116.46 | 2022 | |
| Davol INC. | $675.86 | 2021-2024 | Phasix Mesh |
| Medtronic, INC. | $367.43 | 2023-2024 | Ligasure, Absorbatack, Sonicision |
| Acell, INC. | $110.18 | 2020 | |
| Heron Therapeutics, INC. | $38.57 | 2021-2024 | Zynrelef |
| Integra Lifesciences Corporation | $36.32 | 2021 | |
| Smith+Nephew, INC. | $28.35 | 2025 | Renasys Touch |
| Karl Storz Endoscopy-America | $24.42 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $22.12 | 2023 | Gattex |
| Acacia Pharma INC | $17.05 | 2021 | |
| Kci USA, INC. | $16.48 | 2022 | |
| Ethicon US, LLC | $13.75 | 2024 | Enseal, Echelon Flex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Mcmahon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.